Gain Therapeutics GANX
NASDAQ GANX
$1.11 +0.03 (+2.78%)
At close: Nov 11, 2026 · 4:00 PM EST

Gain Therapeutics (GANX) Net Short-Term Debt Issued (Repaid) (2022 - 2026)

Updated

Analysis

Gain Therapeutics (GANX) Net Short-Term Debt Issued (Repaid) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net ST Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -499.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -682.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -87.00 Mn
10 Gain Therapeutics 47.87 Mn -14.31 Mn - -24,617.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -24,617.00
Jun 30, 2026 -25,297.00
Mar 31, 2026 -25,525.00
Dec 31, 2025 -25,025.00
Sep 30, 2025 -24,996.00
Jun 30, 2025 -24,238.00
Mar 31, 2025 -22,242.00
Dec 31, 2024 -22,780.00
Sep 30, 2024 -23,116.00
Jun 30, 2024 -22,111.00
Mar 31, 2024 -22,872.00
Dec 31, 2023 -22,579.00
Sep 30, 2023 -22,630.00
Jun 30, 2023 -22,246.00
Mar 31, 2023 -21,612.00
Mar 31, 2022 -37,974.00
API Access

Gain Therapeutics Net Short-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=GANX&period=max&api_key=YOUR_API_KEY